{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:31:43Z","timestamp":1791995503717,"version":"4.4.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ajgponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jagp.2024.08.015","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T18:14:19Z","timestamp":1725646459000},"page":"287-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["A Systematic Review of Antidepressants and Psychotherapy Commonly Used in the Treatment of Late Life Depression for Their Effects on Cognition"],"prefix":"10.1016","volume":"33","author":[{"given":"J. Craig","family":"Nelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Gandelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Scott","family":"Mackin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jagp.2024.08.015_bib0001","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States","volume":"75","author":"Hasin","year":"2018","journal-title":"JAMA Psychiatr"},{"key":"10.1016\/j.jagp.2024.08.015_bib0002","article-title":"Suicide mortality in the United States, 1999\u20132019","author":"Hedegaard","year":"2021","journal-title":"NCHS Data Brief"},{"issue":"1","key":"10.1016\/j.jagp.2024.08.015_bib0003","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1192\/bjp.bp.112.112169","article-title":"Differential mortality rates in major and subthreshold depression: meta-analysis of studies that measured both","volume":"202","author":"Cuijpers","year":"2013","journal-title":"Br J Psychiatr"},{"issue":"1","key":"10.1016\/j.jagp.2024.08.015_bib0004","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12916-018-1101-z","article-title":"The association of depression and all-cause and cause-specific mortality: an umbrella review of systematic reviews and meta-analyses","volume":"16","author":"Machado","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.jagp.2024.08.015_bib0005","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archpsyc.61.6.587","article-title":"The nature and determinants of neuropsychological functioning in late-life depression","volume":"61","author":"Butters","year":"2004","journal-title":"Arch Gen Psychiatr"},{"issue":"8","key":"10.1016\/j.jagp.2024.08.015_bib0006","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.eurpsy.2004.09.003","article-title":"Six-month course of mild cognitive impairment and affective symptoms in late-life depression","volume":"19","author":"Adler","year":"2004","journal-title":"Eur Psychiatr"},{"key":"10.1016\/j.jagp.2024.08.015_bib0007","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0033291709990833","article-title":"The pattern and course of cognitive impairment in late-life depression","volume":"40","author":"Kohler","year":"2010","journal-title":"Psychol Med"},{"issue":"3","key":"10.1016\/j.jagp.2024.08.015_bib0008","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3233\/JAD-201089","article-title":"alzheimer's disease neuroimaging initiative; ADNI depression project. The impact of amyloid burden and APOE on rates of cognitive impairment in late life depression","volume":"80","author":"Rhodes","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jagp.2024.08.015_bib0009","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1017\/S1355617714000198","article-title":"Cognitive functioning and late-life depression","volume":"20","author":"Koenig","year":"2014","journal-title":"J Int Neuropsychol Soc"},{"issue":"1","key":"10.1016\/j.jagp.2024.08.015_bib0010","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.biopsych.2005.09.019","article-title":"Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed","volume":"60","author":"Sheline","year":"2006","journal-title":"Biol Psychiatr"},{"issue":"9","key":"10.1016\/j.jagp.2024.08.015_bib0011","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/mp.2013.20","article-title":"The vascular depression hypothesis: mechanisms linking vascular disease with depression","volume":"18","author":"Taylor","year":"2013","journal-title":"Mol Psychiatr"},{"issue":"1","key":"10.1016\/j.jagp.2024.08.015_bib0012","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jagp.2015.05.010","article-title":"A meta-analysis of executive dysfunction and antidepressant treatment response in late-life depression","volume":"24","author":"Pimontel","year":"2016","journal-title":"Am J Geriatr Psychiatr"},{"key":"10.1016\/j.jagp.2024.08.015_bib0013","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00019442-200108000-00011","article-title":"Executive dysfunction and disability in elderly patients with major depression","volume":"9","author":"Kiosses","year":"2001","journal-title":"Am J Geriatr Psychiatr"},{"issue":"5","key":"10.1016\/j.jagp.2024.08.015_bib0014","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1017\/S1355617709990300","article-title":"Impaired financial capacity in late life depression is associated with cognitive performance on measures of executive functioning and attention","volume":"15","author":"Mackin","year":"2009","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/j.jagp.2024.08.015_bib0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrneurol.2011.60","article-title":"Depression and risk of developing dementia","volume":"7","author":"Byers","year":"2011","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"10.1016\/j.jagp.2024.08.015_bib0016","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","article-title":"Depression and risk for Alzheimer disease: systematic review, meta-analysis, and meta-regression analysis","volume":"63","author":"Ownby","year":"2006","journal-title":"Arch Gen Psychiatr"},{"issue":"4","key":"10.1016\/j.jagp.2024.08.015_bib0017","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1600-0447.1961.tb07367.x","article-title":"Pseudo-dementia","volume":"37","author":"Kiloh","year":"1961","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"10.1016\/j.jagp.2024.08.015_bib0018","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/0972-2327.132613","article-title":"Pseudo-dementia: a neuropsychological review","volume":"17","author":"Kang","year":"2014","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.jagp.2024.08.015_bib0019","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1176\/appi.ajp.157.12.1949","article-title":"Changes in cognitive functioning following treatment of late-life depression","volume":"157","author":"Butters","year":"2000","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.jagp.2024.08.015_bib0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3956(02)00085-7","article-title":"Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine","volume":"37","author":"Nebes","year":"2003","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jagp.2024.08.015_bib0021","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jad.2006.01.018","article-title":"Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy","volume":"91","author":"Gallassi","year":"2006","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jagp.2024.08.015_bib0022","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.JGP.0000203130.45421.69","article-title":"Persistence of neuropsychologic deficits in the remitted state of late-life depression","volume":"14","author":"Bhalla","year":"2006","journal-title":"Am J Geriatr Psychiatr"},{"key":"10.1016\/j.jagp.2024.08.015_bib0023","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/gps.895","article-title":"Residual cognitive impairment in late-life depression after a 12-month period follow-up","volume":"18","author":"Portella","year":"2003","journal-title":"Int J Geriatr Psychiatr"},{"key":"10.1016\/j.jagp.2024.08.015_bib0024","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jagp.2013.01.013","article-title":"Patterns of reduced cortical thickness in late-life depression and relationship to psychotherapeutic response","volume":"21","author":"Mackin","year":"2013","journal-title":"Am J Geriatr Psychiatr"},{"key":"10.1016\/j.jagp.2024.08.015_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2017.11.005","article-title":"Anterior-posterior gradient differences in lobar and cingulate cortex cerebral blood flow in late-life depression","volume":"97","author":"Abi Zeid Daou","year":"2018","journal-title":"J Psychiatr Res"},{"issue":"9","key":"10.1016\/j.jagp.2024.08.015_bib0026","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jagp.2017.04.011","article-title":"Cortical atrophy is associated with accelerated cognitive decline in mild cognitive impairment with subsyndromal depression","volume":"25","author":"Gonzales","year":"2017","journal-title":"Am J Geriatr Psychiatr"},{"issue":"10","key":"10.1016\/j.jagp.2024.08.015_bib0027","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/JGP.0b013e3181b4bf4a","article-title":"Change in cognitive functioning following acute antidepressant treatment in late-life depression","volume":"17","author":"Culang","year":"2009","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2024.08.015_bib0028","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1176\/ajp.2007.164.6.900","article-title":"Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial","volume":"164","author":"Raskin","year":"2007","journal-title":"Am J Psychiatr"},{"issue":"4","key":"10.1016\/j.jagp.2024.08.015_bib0029","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/YIC.0b013e3283542457","article-title":"A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder","volume":"27","author":"Katona","year":"2012","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.jagp.2024.08.015_bib0030","series-title":"Handbook of Experimental Pharmacology","doi-asserted-by":"crossref","DOI":"10.1007\/164_2018_170","article-title":"Management of late life depression","author":"Nelson","year":"2018"},{"issue":"1","key":"10.1016\/j.jagp.2024.08.015_bib0031","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/jamainternmed.2023.6279","article-title":"Effect of personalized risk-reduction strategies on cognition and dementia risk profile among older adults: the smarrt randomized clinical trial","volume":"184","author":"Yaffe","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"12","key":"10.1016\/j.jagp.2024.08.015_bib0032","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.jagp.2013.11.002","article-title":"Cognitive outcomes after psychotherapeutic interventions for major depression in older adults with executive dysfunction","volume":"22","author":"Mackin","year":"2014","journal-title":"Am J Geriatr Psychiatr"},{"issue":"8","key":"10.1016\/j.jagp.2024.08.015_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gps.5779","article-title":"Cognitive outcomes are differentially associated with depression severity trajectories during psychotherapy treatment for late life major depressive disorder","volume":"37","author":"Kassel","year":"2022","journal-title":"Int J Geriatr Psychiatr"},{"issue":"9","key":"10.1016\/j.jagp.2024.08.015_bib0034","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jagp.2020.05.023","article-title":"Targeting cognitive control deficits with neuroplasticity-based computerized cognitive remediation in patients with geriatric major depression: a randomized, double-blind, controlled trial","volume":"28","author":"Morimoto","year":"2020","journal-title":"Am J Geriatr Psychiatr"},{"issue":"6","key":"10.1016\/j.jagp.2024.08.015_bib0035","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1176\/appi.ajp.2014.14070889","article-title":"Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial","volume":"172","author":"Lavretsky","year":"2015","journal-title":"Am J Psychiatr"},{"issue":"2","key":"10.1016\/j.jagp.2024.08.015_bib0036","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jagp.2019.08.011","article-title":"A randomized double-blind placebo-controlled trial of combined escitalopram and memantine for older adults with major depression and subjective memory complaints","volume":"28","author":"Lavretsky","year":"2020","journal-title":"Am J Geriatr Psychiatr"},{"issue":"5","key":"10.1016\/j.jagp.2024.08.015_bib0037","doi-asserted-by":"crossref","first-page":"18m12137","DOI":"10.4088\/JCP.18m12137","article-title":"Transdermal nicotine for the treatment of mood and cognitive symptoms in nonsmokers with late-life depression","volume":"79","author":"Gandelman","year":"2018","journal-title":"J Clin Psychiatr"},{"issue":"6, suppl","key":"10.1016\/j.jagp.2024.08.015_bib0038","doi-asserted-by":"crossref","first-page":"82S","DOI":"10.1097\/00004714-198111001-00015","article-title":"Effects of acute administration of trazodone and amitriptyline on cognition, cardiovascular function, and salivation in the normal geriatric subject","volume":"1","author":"Branconnier","year":"1981","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.jagp.2024.08.015_bib0039","first-page":"291","article-title":"Verbal memory and plasma drug concentrations in elderly depressives treated with nortriptyline","volume":"27","author":"Young","year":"1991","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.jagp.2024.08.015_bib0040","series-title":"Textbook of Psychopharmacology","article-title":"Tricyclics and Tetracyclics","author":"Nelson","year":"2024"},{"key":"10.1016\/j.jagp.2024.08.015_bib0041","series-title":"The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation","author":"Reitan","year":"1993"},{"key":"10.1016\/j.jagp.2024.08.015_bib0042","series-title":"Wechsler Adult Intelligence Scale","author":"Wechsler","year":"1997"},{"key":"10.1016\/j.jagp.2024.08.015_bib0043","first-page":"286e340","article-title":"L'examen psychologique dans les cas d'encephalopathie traumatique","volume":"28","author":"Rey","year":"1941","journal-title":"Arch de Psychol (Geneve)"},{"key":"10.1016\/j.jagp.2024.08.015_bib0044","series-title":"Neuropsychological Assessment","first-page":"438","author":"Lezak","year":"1995"},{"key":"10.1016\/j.jagp.2024.08.015_bib0045","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1212\/WNL.24.11.1019","article-title":"Evaluating storage, retention, and retrieval in disordered memory and learning","volume":"24","author":"Buschke","year":"1974","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2024.08.015_bib0046","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/03610738108259795","article-title":"Acquisition and retention of categorized material in normal aging and senile dementia","volume":"7","author":"McCarthy","year":"1981","journal-title":"Exp Aging Res"},{"key":"10.1016\/j.jagp.2024.08.015_bib0047","series-title":"Hopkins Verbal Learning Test - Revised","author":"Brandt","year":"2001"},{"key":"10.1016\/j.jagp.2024.08.015_bib0048","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1037\/0033-2909.109.2.163","article-title":"A half-century of research on the Stroop effect: An integrative review","volume":"109","author":"MacLeod","year":"1991","journal-title":"Psychol Bullet"},{"key":"10.1016\/j.jagp.2024.08.015_bib0049","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023)","year":"2023"},{"key":"10.1016\/j.jagp.2024.08.015_bib0050","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.jagp.2024.08.015_bib0051","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1176\/appi.ajp.157.5.729","article-title":"Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life","volume":"157","author":"Bondareff","year":"2000","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.jagp.2024.08.015_bib0052","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4088\/JCP.v61n0804","article-title":"A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients","volume":"61","author":"Newhouse","year":"2000","journal-title":"J Clin Psychiatr"},{"issue":"1","key":"10.1016\/j.jagp.2024.08.015_bib0053","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jagp.2013.01.019","article-title":"Acute and long-term treatment of late-life major depressive disorder: duloxetine versus placebo","volume":"22","author":"Robinson","year":"2014","journal-title":"Am J Geriatr Psychiatr"},{"issue":"8","key":"10.1016\/j.jagp.2024.08.015_bib0054","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/JGP.0b013e318246b6cb","article-title":"Cognitive improvement following treatment in late-life depression: relationship to vascular risk and age of onset","volume":"20","author":"Barch","year":"2012","journal-title":"Am J Geriatr Psychiatr"},{"issue":"8","key":"10.1016\/j.jagp.2024.08.015_bib0055","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/gps.2783","article-title":"Change in cognitive functioning in depressed older adults following treatment with sertraline or nortriptyline","volume":"27","author":"Culang-Reinlieb","year":"2012","journal-title":"Int J Geriatr Psychiatr"},{"issue":"3","key":"10.1016\/j.jagp.2024.08.015_bib0056","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4088\/JCP.v66n0313","article-title":"Citalopram versus sertraline in late-life nonmajor clinically significant depression: a 1-year follow-up clinical trial","volume":"66","author":"Rocca","year":"2005","journal-title":"J Clin Psychiatr"},{"issue":"2","key":"10.1016\/j.jagp.2024.08.015_bib0057","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/gps.802","article-title":"Sertraline treatment of elderly patients with depression and cognitive impairment","volume":"18","author":"Devanand","year":"2003","journal-title":"Int J Geriatr Psychiatr"},{"issue":"7","key":"10.1016\/j.jagp.2024.08.015_bib0058","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/ijnp\/pyac006","article-title":"Effects of Sodium Benzoate, a D-amino acid oxidase Inhibitor, on perceived stress and cognitive function among patients with Late-Life Depression: a randomized, double-blind, sertraline- and placebo-controlled trial","volume":"25","author":"Lin","year":"2022","journal-title":"Int J Neuropsychopharmacol"},{"issue":"Suppl 20","key":"10.1016\/j.jagp.2024.08.015_bib0059","first-page":"26","article-title":"Cognitive effects of paroxetine in older depressed patients","volume":"60","author":"Nebes","year":"1999","journal-title":"J Clin Psychiatr"},{"issue":"3","key":"10.1016\/j.jagp.2024.08.015_bib0060","first-page":"295","article-title":"Effects of nortriptyline on memory self-assessment and performance in recovered elderly depressives","volume":"27","author":"Meyers","year":"1991","journal-title":"Psychopharmacol Bull"},{"issue":"3","key":"10.1016\/j.jagp.2024.08.015_bib0061","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00004714-199006000-00025","article-title":"The effects of nortriptyline on cognition in elderly depressed patients","volume":"10","author":"Hoff","year":"1990","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jagp.2024.08.015_bib0062","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1017\/S1041610289000141","article-title":"The effects of mood changes and antidepressants on the cognitive capacity of elderly depressed patients","volume":"2","author":"Georgotas","year":"1989","journal-title":"Int Psychogeriat"},{"issue":"2","key":"10.1016\/j.jagp.2024.08.015_bib0063","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1192\/bjp.168.2.149","article-title":"Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial","volume":"168","author":"Roth","year":"1996","journal-title":"Br J Psychiatr"},{"issue":"Suppl 1","key":"10.1016\/j.jagp.2024.08.015_bib0064","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1097\/00002826-199417001-00008","article-title":"Effects of moclobemide on depressive symptoms and cognitive performance in a geriatric population: a controlled comparative study versus imipramine","volume":"17","author":"Pancheri","year":"1994","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"10.1016\/j.jagp.2024.08.015_bib0065","doi-asserted-by":"crossref","first-page":"pyv082","DOI":"10.1093\/ijnp\/pyv082","article-title":"The cognitive effects of antidepressants in major depressive disorder: a systematic review and meta-analysis of randomized clinical trials","volume":"19","author":"Rosenblat","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"issue":"12","key":"10.1016\/j.jagp.2024.08.015_bib0066","doi-asserted-by":"crossref","first-page":"M1137","DOI":"10.1093\/gerona\/58.12.M1137","article-title":"Does antidepressant therapy improve cognition in elderly depressed patients?","volume":"58","author":"Doraiswamy","year":"2003","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"10.1016\/j.jagp.2024.08.015_bib0067","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1076\/anec.10.2.85.14463","article-title":"Stroop interference, practice, and aging","volume":"10","author":"Davidson","year":"2003","journal-title":"Neuropsychol Dev Cogn B Aging Neuropsychol Cogn"},{"issue":"6","key":"10.1016\/j.jagp.2024.08.015_bib0068","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jagp.2017.02.006","article-title":"Improvement in depression is associated with improvement in cognition in late-life psychotic depression","volume":"25","author":"Victoria","year":"2017","journal-title":"Am J Geriatr Psychiatr"},{"issue":"12","key":"10.1016\/j.jagp.2024.08.015_bib0069","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.jagp.2014.02.006","article-title":"Association of age at depression onset with cognitive functioning in individuals with late-life depression and executive dysfunction","volume":"22","author":"Mackin","year":"2014","journal-title":"Am J Geriatr Psychiatr"},{"issue":"1","key":"10.1016\/j.jagp.2024.08.015_bib0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/JGP.0b013e3181256b1d","article-title":"Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression","volume":"16","author":"Sneed","year":"2008","journal-title":"Am J Geriatr Psychiatr"},{"issue":"3","key":"10.1016\/j.jagp.2024.08.015_bib0071","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000209348","article-title":"Does study design influence outcome? the effects of placebo control and treatment duration in antidepressant trials","volume":"78","author":"Rutherford","year":"2009","journal-title":"Psychother Psychosom"},{"issue":"1","key":"10.1016\/j.jagp.2024.08.015_bib0072","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.euroneuro.2008.08.009","article-title":"Does the probability of receiving placebo influence clinical trial outcome? a meta-regression of double-blind, randomized clinical trials in MDD","volume":"19","author":"Papakostas","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"10.1016\/j.jagp.2024.08.015_bib0073","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0893-133X(01)00298-6","article-title":"Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors","volume":"25","author":"Bymaster","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.jagp.2024.08.015_bib0074","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0022-3565(24)37161-7","article-title":"Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites","volume":"283","author":"Owens","year":"1997","journal-title":"J Pharmacol Exper Ther"},{"key":"10.1016\/j.jagp.2024.08.015_bib0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pbb.2013.01.019","article-title":"Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats","volume":"105","author":"M\u00f8rk","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"issue":"12","key":"10.1016\/j.jagp.2024.08.015_bib0076","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/cercor\/bhh097","article-title":"In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors","volume":"14","author":"Puig","year":"2004","journal-title":"Cereb Cortex"},{"issue":"12","key":"10.1016\/j.jagp.2024.08.015_bib0077","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/ijnp\/pyac054","article-title":"Effect of vortioxetine on cognitive impairment in patients with major depressive disorder: a systematic review and meta-analysis of randomized controlled trials","volume":"25","author":"Huang","year":"2022","journal-title":"Int J Neuropsychopharmacol"},{"issue":"12","key":"10.1016\/j.jagp.2024.08.015_bib0078","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0024-3205(93)90194-8","article-title":"Blockade by newly developed antidepressants of biogenic amine uptake into rat brain synaptosomes","volume":"52","author":"Bolden-Watson","year":"1993","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.jagp.2024.08.015_bib0079","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/jpet.102.046532","article-title":"Inhibition of P-glycoprotein by newer antidepressants","volume":"305","author":"Weiss","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.jagp.2024.08.015_bib0080","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00019442-200111000-00012","article-title":"Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers","volume":"9","author":"Furlan","year":"2001","journal-title":"Am J Geriatr Psychiatr"},{"issue":"3","key":"10.1016\/j.jagp.2024.08.015_bib0081","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/026988110101500304","article-title":"Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors","volume":"15","author":"Schmitt","year":"2001","journal-title":"J Psychopharmacol"},{"issue":"19","key":"10.1016\/j.jagp.2024.08.015_bib0082","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.3390\/jcm12196342","article-title":"Association between antidepressants and dementia risk in older adults with depression: a systematic review and meta-analysis","volume":"12","author":"Wang","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jagp.2024.08.015_bib0083","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jagp.2015.12.011","article-title":"Anticholinergic medication use and risk of dementia among elderly nursing home residents with depression","volume":"24","author":"Chatterjee","year":"2016","journal-title":"Am. J. Geriatr. Psychiatr"},{"key":"10.1016\/j.jagp.2024.08.015_bib0084","article-title":"Estimating associations between antidepressant use and incident mild cognitive impairment in older adults with depression","volume":"15","author":"Han","year":"2020","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.jagp.2024.08.015_bib0085","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1177\/0269881120944152","article-title":"Risk of incident dementia in late-life depression treated with antidepressants: a nationwide population cohort study","volume":"34","author":"Su","year":"2020","journal-title":"J Psychopharmacol"},{"issue":"3","key":"10.1016\/j.jagp.2024.08.015_bib0086","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1176\/appi.ajp.2017.17040404","article-title":"Impact of SSRI therapy on risk of conversion from mild ccognitive impairment to Alzheimer's Dementia in individuals with previous depression","volume":"175","author":"Bartels","year":"2018","journal-title":"Am J Psychiatr"},{"issue":"14","key":"10.1016\/j.jagp.2024.08.015_bib0087","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1080\/14656566.2021.1921736","article-title":"An update on antidepressant pharmacotherapy in late-life depression","volume":"22","author":"Brender","year":"2021","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"10.1016\/j.jagp.2024.08.015_bib0088","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.psc.2017.10.009","article-title":"Neurologic changes and depression","volume":"41","author":"Greene","year":"2018","journal-title":"Psychiatr Clin North Am"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748124004433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748124004433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T07:13:39Z","timestamp":1738912419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748124004433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":88,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1064748124004433"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2024.08.015","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Systematic Review of Antidepressants and Psychotherapy Commonly Used in the Treatment of Late Life Depression for Their Effects on Cognition","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Geriatric Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jagp.2024.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}